510(k) Report

510(k) · Cleared

Recalled · Class I · 2023

CereLink ICP Monitor (826820), CereLink ICP Extension Cable (826845)

K232890510(k) TraditionalCleared Feb 4, 2024139-day reviewClass II21 CFR 882.1620Recalls 1 (1 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Integra Lifesciences Production Corporation · GWM Device, Monitoring, Intracranial Pressure

Cleared on Feb 4, 2024 as substantially equivalent to K210993 (Integra Lifesciences Production Corporation, 2021) after a 139-day review. Its family tree reaches back 2 generations to 2019. 2 of the 3 devices in its family, counting itself, have a Class I recall. It has been recalled once, including a Class I recall.

Decided
Feb 4, 2024
Review
139 days
Class
Class II
Product code
GWM
Recalls
1 (1 Class I)
Predicates
1

Its longest line of descent runs back 2 generations to K183406 (2019). No later device cites it as a predicate yet. 2 of the 3 devices in this family, counting this one, have a Class I recall.

  1. Root · 2 generations backK183406 CereLink ICP Monitor, CereLink ICP Extension CableIntegra Lifesciences Corp. · 2019 · Recalled
  2. 1 generation backK210993 CereLink ICP MonitorIntegra Lifesciences Production Corporation · 2021 · Recalled (Class I)
  3. This deviceK232890 CereLink ICP Monitor (826820), CereLink ICP Extension Cable (826845)Integra Lifesciences Production Corporation · 2024

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K183406CereLink ICP Monitor, CereLink ICP Extension CableIntegra Lifesciences Corp.20191
−1K210993CereLink ICP MonitorIntegra Lifesciences Production Corporation2021Class I
0 (this device)K232890CereLink ICP Monitor (826820), CereLink ICP Extension Cable (826845)Integra Lifesciences Production Corporation2024—
FIG. 1 — Lineage of K232890, 2019–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWM device

  1. #1 K252241 Pressio 3 Multi-parameter Neuromonitoring Systemscore 13.0 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K210993CereLink ICP Monitor
Summary page 5
…WM 807.92(a) (3) Predicate Information Predicate Device CereLink ICP Monitor and CereLink ICP Extension Cable K210993 Product Code: GWM 807.92(a) (4) Device Description The CereLink ICP Monitor is indicated…
Integra Lifesciences Production Corporation2021Class I

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (2 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 5, 2023Class IZ-0548-2024Device DesignFirm is expanding the existing recall RES 90457 for the Cerelink, initiated in June 2022, to include all CereLink ICP Extension Cables. The updated corrective action includes a design change to the extension cable to address the "out of…

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K210993CereLink ICP MonitorIntegra Lifesciences Production Corporation · 2021 · Direct predicate · ◆ on the line of descent in FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 5 years and passes through 2 companies; a new generation was cleared every 2.8 years on median.
  • 2 of the 2 ancestors have a recall of any class; 1 has a Class I recall.

How does its category compare?

All GWM devices

GWM Device, Monitoring, Intracranial Pressure: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · GWM

1in 2025

2007: 22008: 22009: 12010: 22011: 32012: 42013: 22014: 22016: 32017: 32018: 12019: 22020: 32021: 22024: 22025: 12026 (partial year): 1
2007high 4 (2012) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWM

30in 2020

2011: 123 days median2012: 100 days median2016: 192 days median2017: 37 days median2020: 30 days median
2007high 192 (2016) · low 30 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWM

3in 2025

2008: 12010: 92011: 62012: 12013: 122014: 22019: 12023: 1, 1 Class I2024: 4, 2 Class I2025: 3
2007high 12 (2013) · low 0 (2007)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · GWM

441in 2025

2007: 1262008: 1052009: 1172010: 1042011: 1842012: 1512013: 1202014: 3602015: 4862016: 4192017: 4452018: 3022019: 2602020: 2682021: 2112022: 4242023: 7442024: 6412025: 441
2007high 744 (2023) · low 104 (2010)2025

MAUDE reports naming product code GWM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—0126
20082—1105
20091—0117
20102—9104
201131236184
201241001151
20132—12120
20142—2360
20150—0486
201631920419
20173370445
20181—0302
20192—1260
20203300268
20212—0211
20220—0424
20230—1 (1)744
20242—4 (2)641
20251—3441
20261—0—

What is it indicated for?

The ICP Monitor is intended for use as an interface between compatible strain gauge type pressure transducers and standard physiological pressure monitoring systems. The ICP Monitor is also intended for use as an independent pressure monitor for displaying the mean, systolic and diastolic values of a physiologic pressure waveform in the absence of an external patient monitor. The CereLink ICP Extension cable is intended for use as a connecting cable between the ICP input channel of the CereLink ICP Monitor and a CereLink ICP Sensor.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K232890: CereLink ICP Monitor (826820), CereLink ICP Extension Cable (826845).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K232890

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026